Cantor Fitzgerald reiterated their overweight rating on shares of DocGo (NASDAQ:DCGO – Free Report) in a report released on Monday,Benzinga reports.
Other research analysts have also issued research reports about the company. Canaccord Genuity Group decreased their target price on DocGo from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday, March 25th. Stifel Nicolaus decreased their target price on DocGo from $4.00 to $2.50 and set a “buy” rating for the company in a research report on Tuesday, March 17th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $3.00 target price on shares of DocGo in a research report on Tuesday, March 17th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $2.38.
Read Our Latest Stock Analysis on DCGO
DocGo Trading Down 1.3%
DocGo (NASDAQ:DCGO – Get Free Report) last issued its earnings results on Monday, May 11th. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.10). The firm had revenue of $75.55 million during the quarter, compared to analyst estimates of $72.48 million. DocGo had a negative return on equity of 44.09% and a negative net margin of 62.23%. On average, sell-side analysts predict that DocGo will post 0.03 earnings per share for the current fiscal year.
Institutional Trading of DocGo
Several hedge funds have recently made changes to their positions in DCGO. Neuberger Berman Group LLC bought a new stake in shares of DocGo in the 4th quarter worth approximately $29,000. Cerity Partners LLC bought a new stake in shares of DocGo in the 2nd quarter worth approximately $37,000. Public Employees Retirement System of Ohio bought a new stake in shares of DocGo in the 4th quarter worth approximately $40,000. Engineers Gate Manager LP bought a new stake in shares of DocGo in the 2nd quarter worth approximately $52,000. Finally, Royce & Associates LP bought a new stake in shares of DocGo in the 3rd quarter worth approximately $64,000. Institutional investors own 56.44% of the company’s stock.
DocGo Company Profile
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Read More
- Five stocks we like better than DocGo
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
